CGN Power (1816) Releases Updated Terms of Reference for Nuclear Safety Committee

Bulletin Express
10/28

CGN Power Co., Ltd. (Stock Code: 1816) has released revised Terms of Reference for its Nuclear Safety Committee, effective upon approval by the Board of Directors on October 28, 2025. The document clarifies the committee’s composition, responsibilities, and regular work processes to ensure the reliability of nuclear power plants and continued focus on nuclear safety.

Under the newly detailed guidelines, the committee consists of five members, all of whom serve as directors of CGN Power, led by the chairman of the Board. It is tasked with reviewing nuclear safety reports, conducting research and necessary oversight, and submitting observations and recommendations to the Board. The committee is required to report its work to the Board at least every half year, highlighting key nuclear safety assessments and potential areas for improvement.

The Terms of Reference also specify that the committee may invite or engage third-party advisors, including certified nuclear safety professionals, at the company’s expense. The administrative office in the Safety, Quality and Environmental Protection Department of CGN Power supports the committee’s day-to-day operations. Additionally, detailed procedures address how meetings are convened, voting rules for adopting resolutions, and protocols for recordkeeping.

The updated guidelines reinforce CGN Power’s emphasis on nuclear safety management, including the review of performance indicators, site inspections, independent investigations, and tracking of corrective measures. Members are required to maintain strict confidentiality, and all actions must adhere to relevant regulations and the Articles of Association. These Terms of Reference and any future revisions remain subject to final Board approval and take effect upon official endorsement.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10